Search insight

Search by
Insight by year

Risk-based Decision Making and Ethical Considerations in Donor Compensation for Plasma-derived Medicinal Products 

Richard Manning, Mark Skinner, Ann Hedlund Hoppe, Henry Grabowski, Raffi Tachdjian, James Crone, and Stuart Youngner
Transfusion
September 2016

Richard Manning joined Mark Skinner, Ann Hedlund Hoppe, Henry Grabowski, Raffi Tachdjian, James Crone, and Stuart Youngner to coauthor a paper supported by Grifols titled “Risk-based Decision Making and Ethical Considerations in Donor Compensation for Plasma-derived Medicinal Products.” In the article, published in Transfusion, the authors integrate stakeholder concerns into an overall risk profile to inform policy considerations around compensated plasma donations. Link to the article.